Cargando…

The construction and analysis of ceRNA networks in invasive breast cancer: a study based on The Cancer Genome Atlas

BACKGROUND: Studies have shown that long noncoding RNAs (lncRNAs) make up the major proportion of the ceRNA network and can regulate gene expression by competitively binding to miRNAs. This reveals the existence of an RNA-miRNA regulatory pathway and is of great biological significance. CeRNAs, as c...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Chundi, Li, Huayao, Zhuang, Jing, Zhang, HongXiu, Wang, Kejia, Yang, Jing, Liu, Cun, Liu, Lijuan, Zhou, Chao, Sun, Changgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301306/
https://www.ncbi.nlm.nih.gov/pubmed/30588106
http://dx.doi.org/10.2147/CMAR.S182521
_version_ 1783381812933820416
author Gao, Chundi
Li, Huayao
Zhuang, Jing
Zhang, HongXiu
Wang, Kejia
Yang, Jing
Liu, Cun
Liu, Lijuan
Zhou, Chao
Sun, Changgang
author_facet Gao, Chundi
Li, Huayao
Zhuang, Jing
Zhang, HongXiu
Wang, Kejia
Yang, Jing
Liu, Cun
Liu, Lijuan
Zhou, Chao
Sun, Changgang
author_sort Gao, Chundi
collection PubMed
description BACKGROUND: Studies have shown that long noncoding RNAs (lncRNAs) make up the major proportion of the ceRNA network and can regulate gene expression by competitively binding to miRNAs. This reveals the existence of an RNA-miRNA regulatory pathway and is of great biological significance. CeRNAs, as competitive endogenous RNAs, have revealed a new mechanism of interaction between RNAs. Until now, the role of lncRNA-mediated ceRNAs in breast cancer and their regulatory mechanisms have been elucidated to some extent. PURPOSE: In this study, comprehensive analysis of large-scale invasive breast cancer samples in TCGA were conducted to further explore the developmental mechanism of invasive breast cancer and the potential predictive markers for invasive breast cancer prognosis in the ceRNA network. METHODS: Abnormal expression profiles of invasive breast cancer associated mRNAs, lncRNAs and miRNAs were obtained from the TCGA database. Through further alignment and prediction of target genes, an abnormal lncRNA-miRNA-mRNA ceRNA network was constructed for invasive breast cancer. Through the overall survival analysis, Identification prognostic bio-markers for invasive breast cancer patients. In addition, we used Cytoscape plug-in BinGo for the different mRNA performance functional cluster analysis. RESULTS: Differential analysis revealed that 1059 lncRNAs, 86 miRNAs, and 2138 mRNAs were significantly different in invasive breast cancer samples versus normal samples. Then we construct an abnormal lncRNA-miRNA-mRNA ceRNA network for invasive breast cancer, consisting of 90 DElncRNAs, 18 DEmiRNAs and 26 DEmRNAs.Further, 4 out of 90 lncRNAs, 3 out of 26 mRNAs, and 2 out of 18 miRNAs were useful as prognostic biomarkers for invasive breast cancer patients (P value < 0.05). It is worth noting that based on the ceRNA network, we found that the LINC00466-Hsa-mir-204- NTRK2 LINC00466-hsa-mir-204-NTRK2 axis was present in 9 RNAs associated with the prognosis of invasive breast cancer. CONCLUSION: This study provides an effective bioinformatics basis for further understanding of the molecular mechanism of invasive breast cancerand for predicting outcomes, which can guide the use of invasive breast cancerdrugs and subsequent related research.
format Online
Article
Text
id pubmed-6301306
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-63013062018-12-26 The construction and analysis of ceRNA networks in invasive breast cancer: a study based on The Cancer Genome Atlas Gao, Chundi Li, Huayao Zhuang, Jing Zhang, HongXiu Wang, Kejia Yang, Jing Liu, Cun Liu, Lijuan Zhou, Chao Sun, Changgang Cancer Manag Res Original Research BACKGROUND: Studies have shown that long noncoding RNAs (lncRNAs) make up the major proportion of the ceRNA network and can regulate gene expression by competitively binding to miRNAs. This reveals the existence of an RNA-miRNA regulatory pathway and is of great biological significance. CeRNAs, as competitive endogenous RNAs, have revealed a new mechanism of interaction between RNAs. Until now, the role of lncRNA-mediated ceRNAs in breast cancer and their regulatory mechanisms have been elucidated to some extent. PURPOSE: In this study, comprehensive analysis of large-scale invasive breast cancer samples in TCGA were conducted to further explore the developmental mechanism of invasive breast cancer and the potential predictive markers for invasive breast cancer prognosis in the ceRNA network. METHODS: Abnormal expression profiles of invasive breast cancer associated mRNAs, lncRNAs and miRNAs were obtained from the TCGA database. Through further alignment and prediction of target genes, an abnormal lncRNA-miRNA-mRNA ceRNA network was constructed for invasive breast cancer. Through the overall survival analysis, Identification prognostic bio-markers for invasive breast cancer patients. In addition, we used Cytoscape plug-in BinGo for the different mRNA performance functional cluster analysis. RESULTS: Differential analysis revealed that 1059 lncRNAs, 86 miRNAs, and 2138 mRNAs were significantly different in invasive breast cancer samples versus normal samples. Then we construct an abnormal lncRNA-miRNA-mRNA ceRNA network for invasive breast cancer, consisting of 90 DElncRNAs, 18 DEmiRNAs and 26 DEmRNAs.Further, 4 out of 90 lncRNAs, 3 out of 26 mRNAs, and 2 out of 18 miRNAs were useful as prognostic biomarkers for invasive breast cancer patients (P value < 0.05). It is worth noting that based on the ceRNA network, we found that the LINC00466-Hsa-mir-204- NTRK2 LINC00466-hsa-mir-204-NTRK2 axis was present in 9 RNAs associated with the prognosis of invasive breast cancer. CONCLUSION: This study provides an effective bioinformatics basis for further understanding of the molecular mechanism of invasive breast cancerand for predicting outcomes, which can guide the use of invasive breast cancerdrugs and subsequent related research. Dove Medical Press 2018-12-17 /pmc/articles/PMC6301306/ /pubmed/30588106 http://dx.doi.org/10.2147/CMAR.S182521 Text en © 2019 Gao et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Gao, Chundi
Li, Huayao
Zhuang, Jing
Zhang, HongXiu
Wang, Kejia
Yang, Jing
Liu, Cun
Liu, Lijuan
Zhou, Chao
Sun, Changgang
The construction and analysis of ceRNA networks in invasive breast cancer: a study based on The Cancer Genome Atlas
title The construction and analysis of ceRNA networks in invasive breast cancer: a study based on The Cancer Genome Atlas
title_full The construction and analysis of ceRNA networks in invasive breast cancer: a study based on The Cancer Genome Atlas
title_fullStr The construction and analysis of ceRNA networks in invasive breast cancer: a study based on The Cancer Genome Atlas
title_full_unstemmed The construction and analysis of ceRNA networks in invasive breast cancer: a study based on The Cancer Genome Atlas
title_short The construction and analysis of ceRNA networks in invasive breast cancer: a study based on The Cancer Genome Atlas
title_sort construction and analysis of cerna networks in invasive breast cancer: a study based on the cancer genome atlas
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301306/
https://www.ncbi.nlm.nih.gov/pubmed/30588106
http://dx.doi.org/10.2147/CMAR.S182521
work_keys_str_mv AT gaochundi theconstructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas
AT lihuayao theconstructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas
AT zhuangjing theconstructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas
AT zhanghongxiu theconstructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas
AT wangkejia theconstructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas
AT yangjing theconstructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas
AT liucun theconstructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas
AT liulijuan theconstructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas
AT zhouchao theconstructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas
AT sunchanggang theconstructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas
AT gaochundi constructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas
AT lihuayao constructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas
AT zhuangjing constructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas
AT zhanghongxiu constructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas
AT wangkejia constructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas
AT yangjing constructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas
AT liucun constructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas
AT liulijuan constructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas
AT zhouchao constructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas
AT sunchanggang constructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas